furazolidone has been researched along with Glycogenosis in 2 studies
Furazolidone: A nitrofuran derivative with antiprotozoal and antibacterial activity. Furazolidone acts by gradual inhibition of monoamine oxidase. (From Martindale, The Extra Pharmacopoeia, 30th ed, p514)
furazolidone : A member of the class of oxazolidines that is 1,3-oxazolidin-2-one in which the hydrogen attached to the nitrogen is replaced by an N-{[(5-nitro-2-furyl)methylene]amino} group. It has antibacterial and antiprotozoal properties, and is used in the treatment of giardiasis and cholera.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Czarnecki, CM | 2 |
Jegers, A | 1 |
Jankus, EF | 2 |
Salam, A | 1 |
Caldwell, R | 1 |
2 other studies available for furazolidone and Glycogenosis
Article | Year |
---|---|
Characterization of glycogen in selected tissues of turkey poults with spontaneous round heart disease and furazolidone-induced cardiomyopathy.
Topics: Animals; Cardiomyopathies; Furazolidone; Glucose; Glycogen; Glycogen Storage Disease; Glycogen Stora | 1978 |
Activity of alpha-1, 4-glucosidase in furazolidone-induced glycogenosis.
Topics: alpha-Glucosidases; Animals; Furazolidone; Glucosidases; Glycogen Storage Disease; Liver; Male; Poul | 1978 |